OSHA's August 19 Hearing on the Carcinogen and Respirator Proposals: What's Changing, What Isn't, and Why You Shouldn't Touch Your Program Yet
← Back to Blog Safety

OSHA's August 19 Hearing on the Carcinogen and Respirator Proposals: What's Changing, What Isn't, and Why You Shouldn't Touch Your Program Yet

OSHA's Aug 19, 2026 hearing covers 20+ deregulatory proposals affecting respirator rules across 13 carcinogen standards. The exposure limits are not changing. Here's what's actually on the table.

by iSi Environmental

OSHA’s August 19 Hearing on the Carcinogen and Respirator Proposals: What’s Changing, What Isn’t, and Why You Shouldn’t Touch Your Program Yet

OSHA is holding an informal public hearing on August 19, 2026 covering more than 20 proposed rule changes, and the headline items for industrial and manufacturing employers are the proposals that would loosen respirator-selection requirements across 13 substance-specific carcinogen standards — benzene, asbestos, lead, cadmium, formaldehyde, and others. If you run a respiratory protection program tied to any of those standards, here is the single most important thing to understand before you read another word: the permissible exposure limits for these carcinogens are not changing. Not one of them. The proposals touch respirator-selection mechanics and duplicative recordkeeping, not the exposure thresholds your industrial hygiene program is built around.

This is deregulatory rulemaking — OSHA proposing to remove or relax requirements, not add them. Nothing here is final, nothing here is a new compliance burden, and the smartest move most facilities can make right now is to change nothing. This piece walks through exactly what OSHA proposed, when the hearing happens, what is and isn’t on the table, and the one genuine risk in this story: relaxing a program before a final rule exists.

For the related proposal to drop medical evaluations for N95s and loose-fitting PAPRs, we covered that in detail in OSHA Respiratory Protection Medical Evaluations in 2026. For the broader rulemaking package — heat, HazCom, withdrawn lead rules — see OSHA Health Standards Rulemaking in 2026. This post focuses on the August 19 hearing and the 13-carcinogen respirator consolidation specifically.

What is OSHA proposing to change for carcinogen standards in 2026?

OSHA proposes to delete respirator-selection provisions in 13 substance-specific standards — benzene, asbestos, cadmium, formaldehyde, lead, and others — that duplicate the general respiratory-protection standard at 29 CFR 1910.134. The permissible exposure limits are not changing — only the respirator-selection mechanics and the duplicative requirements.

Here is the structural problem OSHA says it is fixing. When the substance-specific carcinogen standards were written, each one carried its own respirator-selection table and its own provisions. The general respiratory protection standard at 1910.134 was later built out with modern assigned-protection-factor tables that cover the same ground. The result is two sets of rules saying overlapping things, and in some cases the substance-specific text restricts respirator selection more narrowly than 1910.134 would. OSHA’s proposal deletes the duplicative substance-specific provisions and “removes unnecessary restrictions on respirator selection where another equally protective option exists.”

The 13 standards in scope are 1,2-dibromo-3-chloropropane; 1,3-butadiene; the “13 Carcinogens” standard (4-nitrobiphenyl and others); acrylonitrile; asbestos; benzene; cadmium; coke oven emissions; cotton dust; ethylene oxide; formaldehyde; inorganic arsenic; lead; methylene chloride; methylenedianiline; and vinyl chloride. If your written program cites a respirator table out of one of those standards, this proposal is the one to track.

Is OSHA lowering or raising exposure limits for benzene, asbestos, or lead?

No. These deregulatory proposals do not change the permissible exposure limits (PELs) for any of the 13 substances. OSHA is proposing to remove duplicative respirator-selection language and allow equally protective respirator options — the underlying exposure thresholds and the substances’ carcinogen classifications are untouched (FR 2026-11126).

This is the point most coverage gets wrong by omission. A “deregulatory action on carcinogen standards” sounds like OSHA is letting workers be exposed to more benzene or asbestos. It is not. The asbestos PEL, the lead action level, the benzene 8-hour TWA — those numbers are not in this rulemaking. The substances are still classified as carcinogens. What changes, if finalized, is the mechanics of how an employer picks a respirator and which redundant paperwork survives. If your IH sampling program is built around the exposure limits — and it should be — nothing in these proposals requires you to recalibrate a single sampling protocol.

When is the OSHA public hearing on the 2026 deregulatory proposals?

OSHA’s virtual informal public hearings begin Wednesday, August 19, 2026 at 9:30 a.m. EST, covering more than 20 proposed rules. Parties intending to testify or question witnesses had to file a Notice of Intention to Appear by July 6, 2026 (FR 2026-11126, published June 3, 2026).

This hearing is the formal record-building step in the rulemaking, not the finish line. It is where OSHA hears testimony, evidence, and cross-examination on the proposals before deciding whether to finalize any of them. The proposals trace back to July 1, 2025, when OSHA published 25 proposed rules and one final rule in the Federal Register — its largest single-day deregulatory action in decades — under Executive Order 14192, “Unleashing Prosperity Through Deregulation”. The August 19 hearing pulls more than 20 of those proposals into one consolidated proceeding. After the hearing comes a post-hearing comment window, then OSHA’s review, then — only then — any final rule.

What is OSHA changing about respirator medical evaluations?

OSHA proposes to remove the medical-evaluation requirement in the Respiratory Protection Standard for two respirator types only: filtering facepiece respirators (FFRs) and loose-fitting powered air-purifying respirators (PAPRs). OSHA cites insufficient evidence that pre-use evaluations meaningfully reduce harm for these low-burden respirators. Medical evaluations for other respirator types remain (FR 2025-12235).

This medical-evaluation proposal is separate from the 13-carcinogen respirator-selection consolidation, but it travels in the same deregulatory package and reaches a much larger population of employers — anyone issuing N95-type disposables or loose-fitting PAPRs in manufacturing, food processing, woodworking, or general maintenance. The proposal does not touch medical evaluations for tight-fitting elastomeric respirators, supplied-air respirators, or SCBAs, and it does not touch the independent medical-surveillance requirements built into chemical-specific standards like asbestos, lead, and cadmium. We walk through the full detail — including the 5-4 advisory committee vote against proceeding — in our medical-evaluation post.

Do I still need medical evaluations for N95 respirators right now?

Yes. The FFR/PAPR medical-evaluation removal is a proposed rule, not final. As of June 2026, the existing 29 CFR 1910.134 medical-evaluation requirements remain fully in force and enforceable. Employers should not drop evaluations until a final rule publishes.

A proposal in the Federal Register changes nothing about what you are required to do today. If your workers use respirators — including N95s — without current medical clearance under 1910.134(e), you are exposed to a citation under the standard as it exists right now. The questionnaire requirement, the licensed-health-care-professional review, the fit-testing sequence that follows clearance — all of it is intact and enforced. Acting on a proposal as though it were a rule is the fastest way to convert a deregulatory headline into a citation.

What is the OSHA General Duty Clause proposal about?

OSHA proposes to interpret the General Duty Clause (29 U.S.C. § 654(a)(1)) so it does not reach hazards inherent and inseparable from the core nature of certain professional or performance activities — live entertainment, professional and extreme sports, animal handling, motorsports. Employers would still owe reasonable controls. The comment period closed September 2, 2025 (FR 2025-12236).

The General Duty Clause is OSHA’s catch-all enforcement tool for recognized hazards that have no specific standard attached. This proposal would carve out a narrow category of activities where the hazard is the point of the work — you cannot make bull riding hazard-free without ending bull riding. It is one of the more legally contested pieces of the package, which is why it draws attention well beyond the industries it actually targets.

Does the General Duty Clause change affect manufacturers?

Largely no. The proposal targets “inherently risky” professional and performance occupations — entertainment, sports, tactical training — not routine manufacturing hazards. General Duty Clause enforcement for recognized manufacturing hazards like heat, combustible dust, and workplace violence is not the subject of this proposal (FR 2025-12236).

If you run a plant, a foundry, a chemical-processing line, or a fabrication shop, the GDC change is not your story. The hazards OSHA cites under the General Duty Clause in your environment — heat exposure with no heat standard in federal-OSHA states, combustible dust, ergonomic and workplace-violence hazards — are not “inherent and inseparable” from the core nature of a professional activity in the way a stunt or an animal act is. Do not read this proposal as loosening GDC enforcement on the manufacturing floor. It does not.

Why is OSHA deregulating in 2025 and 2026?

The package implements Executive Order 14192, “Unleashing Prosperity Through Deregulation,” which directs agencies to cut compliance costs and remove duplicative or outdated requirements. OSHA frames the 25 proposed rules as modernization — eliminating substance-specific provisions that duplicate the general respiratory standard and reducing low-value administrative steps.

OSHA’s stated logic is that decades of overlapping rulemaking left the standards carrying redundant text — substance-specific respirator tables that say nothing the modern 1910.134 framework doesn’t already cover, medical-evaluation triggers for low-burden respirators that the agency says lack a supporting evidence base, and paperwork that duplicates other recordkeeping. Whether you find that rationale persuasive or not, the practical takeaway is the same: these are framed as flexibilities and simplifications, available only if finalized, not obligations.

Are OSHA penalties going up in 2026?

No. These are deregulatory proposals; they do not change penalty amounts. Current maximums remain $16,550 per serious violation and $165,514 per willful or repeat violation — figures carried forward with no 2026 inflation adjustment applied (OSHA penalties). The proposals reduce or simplify requirements; they do not raise penalties.

This matters because the deregulatory framing can get garbled into “OSHA is cracking down.” It is not. The penalty schedule is frozen at the 2025 levels — the 2026 inflation adjustment was canceled — and these proposals would, if anything, narrow what is citable, not widen it. What the frozen penalty numbers do tell you is the cost of getting the timing wrong: if you relax a program based on a proposal that never finalizes, the citation you draw under the still-in-force standard is priced at $16,550 per serious instance and up to $165,514 for a willful one.

What should employers do now about the OSHA proposals?

Track the rulemaking and decide whether to comment, but change nothing yet. All current PELs, respirator-selection rules, and medical-evaluation requirements remain enforceable until final rules publish. Relaxing protections before finalization — or assuming a State Plan state will follow — creates citation risk under standards still in force (FR 2026-11126).

The accurate to-do list is short and unglamorous. First, identify whether your written respiratory protection program cites a substance-specific carcinogen standard’s respirator table, and whether you medically evaluate FFR or PAPR users — that tells you whether any of this reaches you at all. Second, decide whether the August 19 hearing or the docket comment windows are worth engaging. Third, if and when a final rule publishes, reconcile your written program — but only then, and only where the alternative is genuinely equally protective. Fourth, leave your protections in place in the meantime. There is no version of acting early on these proposals that reduces your risk; every version increases it.

Will state OSHA plans adopt these rollbacks?

Not automatically. The 22 State Plan states must maintain standards “at least as effective as” federal OSHA, but a federal rollback does not compel a state to loosen. States may retain the stricter substance-specific respirator and medical-evaluation requirements, creating a federal/state split for multi-state employers (OSHA State Plans).

This is the angle most generic coverage misses, and it is the one that bites multi-state operators. The “at least as effective as” standard is a floor, not a ceiling — it stops a State Plan state from going below federal OSHA, but nothing forces a state to follow federal OSHA down when the federal requirements relax. A state can keep the stricter pre-rollback respirator-selection and medical-evaluation rules in place. For iSi’s core region, Kansas, Nebraska, Oklahoma, and Missouri operate under federal OSHA for private-sector work, while markets like California run their own programs through Cal/OSHA. A manufacturer with plants in both a federal-OSHA state and a State Plan state could end up running two different programs after a final federal rule — verify each operating state’s plan status before you change a written program anywhere.

The Counter-Signal: Why Status Quo Is the Most Likely Near-Term Reality

It would be a mistake to write as though these changes are coming, because the pushback is real and material.

Worker-safety advocates and a former NLRB chair argued in public comments that the General Duty Clause proposal is unlawful and should not proceed (Public Citizen comments) — which means litigation could delay or block finalization. Several practitioner analyses characterize the GDC change as “much ado about nothing” in practice, because employers still owe reasonable controls regardless, so the real-world effect may be smaller than the headline suggests. And as covered above, State Plan states can decline to follow, so even a finalized federal rollback may not reach a large share of the manufacturing workforce.

Add it up: the proposals are not final, they face hearing testimony, post-hearing comment, agency review, and probable litigation. The most likely near-term reality for most employers is not relief — it is status quo. Plan accordingly.

The Practitioner Takeaway: The Risk Here Is Acting Too Early

There is no new enforcement action in this story. These are proposed rules, not an enforcement initiative. The relevant enforcement point is the opposite of urgency: because the proposals are not final, OSHA continues to enforce the existing substance-specific carcinogen standards, the existing 1910.134 medical-evaluation requirements, and the existing General Duty Clause exactly as they read today.

So the compliance risk in this rulemaking is not that you will miss a new obligation. It is that you will relax a respiratory protection program based on a proposal that has not finalized — drop a medical evaluation, swap to a less protective respirator under a substance-specific table that hasn’t actually been deleted — and draw a citation under the standard still in force. One willful instance is priced at up to $165,514. There is no scenario where moving early here protects you.

If you want a clear read on whether any of this reaches your facility, the answer is in your program documentation, not the Federal Register: does your written respiratory protection program cite a substance-specific carcinogen standard’s respirator table, and do you medically evaluate FFR or PAPR users? A respiratory protection program review — typically part of an industrial hygiene assessment — answers that in a structured way and tells you what, if anything, you would need to change after a final rule, without exposing you to risk in the meantime. iSi includes a written respiratory protection program review as a standard component of its industrial hygiene work and OSHA compliance support. If your program has been on autopilot, that review is where to start — not the rulemaking docket.

Want to know whether the carcinogen and respirator proposals touch your program? Talk to iSi about a respiratory protection program review. We will tell you what is actually in scope for your facility, what stays exactly as it is, and what — if a final rule ever publishes — you would need to reconcile. Get in touch.

Sources

Tags: